Pfizer/BioNTech Expect Data on Shot’s Protection Against New COVID-19 Variant Soon

FRANKFURT — BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant https://www.reuters.com/business/healthcare-pharmaceuticals/what-we-know-about-covid-19-variant-detected-south-africa-2021-11-26 detected in South Africa within two weeks to help determine whether its vaccine produced with partner Pfizer Inc would have to be reworked. Read More